WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) today lauded Congressional passage of the “Small Business Early-Stage Investment Program,” which will provide $1 billion in grants for venture capital investments in certain industries, including life sciences. The measure is contained in Title III of H.R. 5297, the Small Business Lending Fund Act of 2010.
